Anti-PI 3 Kinase catalytic subunit gamma/PI3K-gamma antibody [OTI4H9]
Be the first to review this product! Submit a review
|
(10 Publications)
Mouse Monoclonal PI 3 Kinase catalytic subunit gamma/PI3K-gamma antibody. Suitable for WB and reacts with Human samples. Cited in 10 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human PIK3CG.
View Alternative Names
PI3-kinase subunit gamma, PI3K-gamma, PI3Kgamma, PtdIns-3-kinase subunit gamma, Phosphoinositide-3-kinase catalytic gamma polypeptide, Serine/threonine protein kinase PIK3CG, p120-PI3K, PtdIns-3-kinase subunit p110-gamma, p110gamma, PIK3CG
- WB
Lab
Western blot - Anti-PI 3 Kinase catalytic subunit gamma/PI3K-gamma antibody [OTI4H9] (AB139307)
Western blot : Anti-PIK3CG antibody [OTI4H9] (ab139307) staining at 1/1000 dilution, shown in green; Rabbit anti-alpha Tubulin antibody [EP1332Y] (ab52866) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab139307 was shown to bind specifically to PIK3CG. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-PI 3 Kinase catalytic subunit gamma/PI3K-gamma antibody [OTI4H9] (ab139307) at 1/1000 dilution
Lane 1:
K562 cell lysate at 20 µg
Lane 2:
Jurkat cell lysate at 20 µg
Lane 3:
SW480 cell lysate at 20 µg
Lane 4:
A549 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution
Predicted band size: 126 kDa
Observed band size: 126 kDa
false
- WB
Unknown
Western blot - Anti-PI 3 Kinase catalytic subunit gamma/PI3K-gamma antibody [OTI4H9] (AB139307)
All lanes:
Western blot - Anti-PI 3 Kinase catalytic subunit gamma/PI3K-gamma antibody [OTI4H9] (ab139307) at 1/1000 dilution
Lane 1:
HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) cell lysate transfected with pCMV6-ENTRY control at 5 µg
Lane 2:
HEK-293T cell lysate transfected with pCMV6-ENTRY PI 3 Kinase catalytic subunit gamma/PI3K-gamma cDNA at 5 µg
Predicted band size: 126 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PI3K-gamma plays an important role in mediating immune responses. It is a part of a larger dimeric complex coupling with a regulatory subunit to modulate its activity and specificity. This complex formation is vital in regulating leukocyte chemotaxis endothelial cell migration and cardiac function. Signaling through PI3K-gamma influences the activation and migration of immune cells aiding in the body's defense mechanism against infections and inflammation. Additionally the protein regulates heart contractility contributing to cardiac physiology.
Pathways
PI3K-gamma is an essential component in the PI3K-Akt signaling pathway. This pathway modulates various cellular processes including cell proliferation survival and metabolism. Reports link PI3K-gamma to the regulation of mTOR pathway which further affects protein synthesis and autophagy. Within these pathways it aligns with proteins such as Akt and mTORC1 facilitating signals that control cell growth and resistance to apoptosis. These pathways demonstrate the enzyme's involvement in maintenance of cellular homeostasis and adaptability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Discover oncology 16:88 PubMed39864021
2025
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e34192 PubMed39100446
2024
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 19:20240991 PubMed39091610
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed38069135
2023
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9:e2200546 PubMed35901491
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 9:929030 PubMed35845066
2022
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medicine : eCAM 2022:3849441 PubMed35463064
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neuropsychiatric disease and treatment 18:513-524 PubMed35280979
2022
Applications
Unspecified application
Species
Unspecified reactive species
IUBMB life 73:866-882 PubMed33759343
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of experimental pathology 101:203-214 PubMed32985776
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com